https://www.prnewswire.com/news-releases/pulmatrix-presents-pur3100-phase-1-data-at-the-65th-annual-meeting-of-the-american-headache-society-301852038.html
/PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious...
presentsphasedataannual
https://americanheadachesociety.org/news/atogepant-receives-fda-approval-for-the-preventive-treatment-of-episodic-migraine-in-adults
american headache society
https://ec2-35-171-119-65.compute-1.amazonaws.com/news
Stay updated on AHS news, society announcements, and the latest developments in headache research, education, and advocacy.
american headache societynewsindex
https://www.ajmc.com/view/american-headache-society-includes-cgrp-inhibitors-in-updated-consensus-statement
Providing healthcare professionals with up-to-date guidance for the use of preventive and acute treatments for migraine, the American Headache Society has...
american headache societyincludescgrpinhibitorsupdated